IMT-380

N/A

Report date: 2025/08/27 15:48:11

Base Information

Drug NameIMT-380
Drug Alias NameIMT-380
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionKiller cell lectin-like receptor subfamily B member 1 inhibitors
TargetsKiller cell lectin-like receptor subfamily B member 1
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunitas Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunitas Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A